HCA Healthcare (HCA)
Technical, fundamental, and sentiment analysis with recent related videos.
HCA rates Neutral overall. The fundamental read is neutral: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.68); revenue is growing about 7.9% per year; net income is growing about 6.9% per year. The technical picture is neutral: price is 1.5% above the 200-day moving average; 3.8% above the 50-day; the 50/200 relationship is in a Death cross. Sentiment is neutral (composite 55/100), based on 8 news articles from recent coverage.
Revenue 3-year avg +7.9%. Net income 3-year avg +6.9%.
Price vs 20DMA -0.3%. RSI 50.91. Bollinger state: Inside Bands.
Composite score 55/100 from the AI judge, based on 8 news items, 0 television segments, and 0 videos.
Latest Market Read
All three badges sit at Neutral. The Fundamental rating is Neutral with revenue averaging 7.9 percent per year and net income averaging 6.9 percent per year, and no outlier distortion. The Technical rating is Neutral: the Relative Strength Index (RSI), a momentum reading, is 50.9, price sits about 0.3 percent below its 20-day moving average, and the price is inside the Bollinger Bands. The Sentiment composite is 55/100, a Neutral band; coverage leans constructive on an earnings beat but not strong enough to flip the label, leaving the overall rating Neutral.
Recent news: Coverage is mixed: HCA reported Q3 results that beat estimates with EPS of $7.22, revenue above expectations, admissions growth and a raised midpoint inside its 2026 guidance, but management flagged payer‑mix pressure and forecast $550M–$650M lower Medicaid supplemental benefits for 2027. The positive operational beat and improved cost performance are tempered by guidance headwinds and visible investor unease, as shares fell over 5% and traded near $445. The GDELT tone of 52/100 offers a mild supportive context but does not overcome the offsetting signals.
Latest Videos
- No qualified videos yet.